Description

1,6,7,8-Indolizinetetrol, Octahydro-, 1,6,8-Triacetate, 1S-(1.Alpha.,6.Beta.,7.Alpha.,8.Beta.,8A.Beta.)- is a complex, stereochemically defined indolizine derivative, serving as a high-value synthetic intermediate and building block in advanced organic synthesis. Its precise stereochemistry and functional group array make it a critical precursor for the development of novel pharmaceutical compounds and fine chemicals. This product is essential for research and development chemists in the pharmaceutical, agrochemical, and specialty chemical industries seeking to construct complex molecular architectures with high selectivity.

Application

• Pharmaceutical Intermediate: Key chiral building block for the synthesis of potential active pharmaceutical ingredients (APIs), particularly in alkaloid and heterocyclic chemistry.
• Organic Synthesis Reagent: Used in multi-step syntheses to introduce the indolizine core or specific acetylated polyol functionalities into target molecules.
• Medicinal Chemistry Research: A valuable scaffold for drug discovery programs targeting neurological, metabolic, or infectious diseases.
• Agrochemical Development: Intermediate in the research and synthesis of novel, biologically active compounds for crop protection.
• Academic & Industrial R&D: Used in universities and corporate labs for methodological studies in stereoselective synthesis and natural product analog development.

Basic Information

Product Name	1,6,7,8-Indolizinetetrol, Octahydro-, 1,6,8-Triacetate, 1S-(1.Alpha.,6.Beta.,7.Alpha.,8.Beta.,8A.Beta.)-
CAS No.	156150-92-4
Molecular Formula	C14H22O7
Molecular Weight	302.32 g/mol
Synonyms	(1S,6R,7S,8R,8aR)-Octahydro-1,6,7,8-indolizinetetrol 1,6,8-Triacetate; 1,6,8-Tri-O-acetyl-1,6,7,8-tetrahydroxyoctahydroindolizine; 1S-(1α,6β,7α,8β,8aβ)-Octahydro-1,6,7,8-indolizinetetrol 1,6,8-Triacetate; Indolizine-1,6,8-triol Tetraacetate Derivative; Stereoisomer of Swainsonine Triacetate; Polyhydroxylated Indolizidine Triacetate; CAS 156150-92-4.
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards. Every batch is characterized using advanced analytical techniques including HPLC, GC, NMR, and mass spectrometry to confirm identity, purity, and stereochemical integrity. Certificates of Analysis (COA) detailing batch-specific results are available upon request. We adhere to a cGMP-compliant quality management system suitable for pharmaceutical development applications.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a dry, well-ventilated area. This compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed under an inert atmosphere if specified. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Specific Rotation	Contact for details
Water Content (KF)	≤ 0.5%
Residual Solvents (GC)	Meets ICH guidelines
Heavy Metals	< 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.